Whether these drugs will have a place in the treatment of patients with kidney cancer, whether this treatment will be affected by Wnt-4 expression, and whether the drugs should be used alone or in combination with some other novel treatment options for metastatic renal cancer remains to be determined [26,27]. Here, WNT4 is linked to kidney cancer.